INTRODUCTION:
The introduction of a new pharmaceutical product into an existing manufacturing facility is a multidisciplinary activity involving product development/technology transfer, manufacturing, quality control, quality assurance, engineering, validation, warehouse, regulatory affairs and supply chain functions.
The proposed product covered by this assessment is:
Ursodeoxycholic Acid 300 mg Tablet
Introduction of the product into an existing facility may introduce new risks related to:
- Raw material characteristics
- API handling
- Material dispensing
- Formulation and manufacturing process
- Granulation/blending
- Compression
- Coating, where applicable
- Cleaning and cross-contamination
- Equipment suitability
- Manufacturing capacity
- Analytical testing
- Method transfer/verification
- Process validation
- Cleaning validation
- Packaging
- Stability
- Storage conditions
- Personnel competency
- Documentation
- Computerized systems
- Regulatory compliance
- Product-specific hold times
- Supply-chain requirements
The attached FMEA methodology emphasizes evaluating the process from the relevant starting point through storage/use and considers equipment, environmental controls, personnel, documentation, deviation, CAPA, change control and periodic QRM review.
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
Click the link to get the word file copy of this document:
Key Parameter of the Below Page:
FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
Find below pages for complete report
